mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.5 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
palmostatin B |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.5 |
mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.5 |
mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.5 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.5 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.5 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |